Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 728480, 10 pages
http://dx.doi.org/10.1155/2012/728480
Review Article

Recurrent Herpetic Stromal Keratitis in Mice: A Model for Studying Human HSK

1Department of Ophthalmology, Saint Louis University School of Medicine, 1402 S. Grand Blvd., Schwitalla Hall, Room M99, St. Louis, MO 63104-1004, USA
2Department of Biology, Washington University School of Medicine, St. Louis, MO 63104, USA

Received 16 December 2011; Revised 20 February 2012; Accepted 20 February 2012

Academic Editor: Lbachir BenMohamed

Copyright © 2012 Patrick M. Stuart and Tammie L. Keadle. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Pepose, D. A. Leib, P. M. Stuart, and E. L. Easty, “Herpes simplex virus diseases: anterior segment of the eye,” in Ocular Infection and Immunity, J. S. Pepose, G. A. N. Holland, and K. R. Wilhelmus, Eds., pp. 905–932, Mosby, St. Louis, Mo, USA, 1996. View at Google Scholar
  2. J. Thomas, S. Gangappa, S. Kanangat, and B. T. Rouse, “On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis,” Journal of Immunology, vol. 158, no. 3, pp. 1383–1391, 1997. View at Google Scholar · View at Scopus
  3. J. Maertzdorf, G. M. Verjans, L. Remeijer, A. van der Kooi, and A. D. Osterhaus, “Restricted T cell receptor beta-chain variable region protein use by cornea-derived CD4+ and CD8+ herpes simplex virus-specific T cells in patients with herpetic stromal keratitis,” Journal of Infectious Diseases, vol. 187, no. 4, pp. 550–558, 2003. View at Google Scholar
  4. S. J. Divito and R. L. Hendricks, “Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis,” Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1488–1495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. R. Rinne, S. Z. Abghari, and R. D. Stulting, “The severity of herpes simplex viral keratitis in mice does not reflect the severity of disease in humans,” Investigative Ophthalmology and Visual Science, vol. 33, no. 2, pp. 268–272, 1992. View at Google Scholar · View at Scopus
  6. T. J. Liesegang, “Herpes simplex virus epidemiology and ocular importance,” Cornea, vol. 20, no. 1, pp. 1–13, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. K. R. Wilhelmus, D. J. Coster, and H. C. Donovan, “Prognostic indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration,” Archives of Ophthalmology, vol. 99, no. 9, pp. 1578–1582, 1981. View at Google Scholar
  8. J. K. Miller, K. A. Laycock, J. A. Umphress, K. K. Hook, P. M. Stuart, and J. S. Pepose, “A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice,” Cornea, vol. 15, no. 5, pp. 497–504, 1996. View at Google Scholar · View at Scopus
  9. T. L. Keadle, K. A. Laycock, J. K. Miller et al., “Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice,” Journal of Infectious Diseases, vol. 176, no. 2, pp. 331–338, 1997. View at Google Scholar · View at Scopus
  10. S. D. Cook, M. J. Paveloff, J. J. Doucet, A. J. Cottingham, F. Sedarati, and J. M. Hill, “Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants,” Investigative Ophthalmology and Visual Science, vol. 32, no. 5, pp. 1558–1561, 1991. View at Google Scholar · View at Scopus
  11. C. Shimeld, T. Hill, B. Blyth, and D. Easty, “An improved model of recurrent herpetic eye disease in mice,” Current Eye Research, vol. 8, no. 11, pp. 1193–1205, 1989. View at Google Scholar · View at Scopus
  12. C. Shimeld, T. J. Hill, W. A. Blyth, and D. L. Easty, “Reactivation of latent infection and induction of recurrent herpetic eye disease in mice,” Journal of General Virology, vol. 71, no. 2, pp. 397–404, 1990. View at Google Scholar · View at Scopus
  13. C. Shimeld, T. J. Hill, W. A. Blyth, and D. L. Easty, “Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system,” Journal of General Virology, vol. 71, no. 3, pp. 681–687, 1990. View at Google Scholar · View at Scopus
  14. K. A. Laycock, S. F. Lee, R. H. Brady, and J. S. Pepose, “Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation,” Investigative Ophthalmology and Visual Science, vol. 32, no. 10, pp. 2741–2746, 1991. View at Google Scholar · View at Scopus
  15. P. M. Stuart, B. Summers, J. E. Morris, L. A. Morrison, and D. A. Leib, “CD8+ T cells control corneal disease following ocular infection with herpes simplex virus type 1,” Journal of General Virology, vol. 85, no. 7, pp. 2055–2063, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. Morris, S. Zobell, X. T. Yin et al., “Mice with mutations in fas and fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1,” Journal of Immunology, vol. 188, no. 2, pp. 793–799, 2012. View at Publisher · View at Google Scholar
  17. N. M. Sawtell and R. L. Thompson, “Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia,” Journal of Virology, vol. 66, no. 4, pp. 2150–2156, 1992. View at Google Scholar · View at Scopus
  18. N. M. Sawtell, “Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation,” Journal of Virology, vol. 77, no. 7, pp. 4127–4138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. D. M. Neumann, P. S. Bhattacharjee, and J. M. Hill, “Sodium butyrate: a chemical inducer of in vivo reactivation of herpes simplex virus type 1 in the ocular mouse model,” Journal of Virology, vol. 81, no. 11, pp. 6106–6110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. K. Newell, S. Martin, D. Sendele, C. M. Mercadal, and B. T. Rouse, “Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology,” Journal of Virology, vol. 63, no. 2, pp. 769–775, 1989. View at Google Scholar · View at Scopus
  21. Y. H. Su, X. T. Yan, J. E. Oakes, and R. N. Lausch, “Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection,” Journal of Virology, vol. 70, no. 2, pp. 1277–1281, 1996. View at Google Scholar · View at Scopus
  22. H. Ghiasi, S. Cai, G. C. Perng, A. B. Nesburn, and S. L. Wechsler, “Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring,” British Journal of Ophthalmology, vol. 84, no. 4, pp. 408–412, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. R. L. Kintner and C. R. Brandt, “The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of ocular HSV-1 infection,” Current Eye Research, vol. 14, no. 2, pp. 145–152, 1995. View at Google Scholar · View at Scopus
  24. P. S. Bhattacharjee, D. M. Neumann, T. P. Foster et al., “Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model,” Investigative Ophthalmology and Visual Science, vol. 49, no. 10, pp. 4263–4268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. R. M. Strieter, T. J. Standiford, G. B. Huffnagle, L. M. Colletti, N. W. Lukacs, and S. L. Kunkel, ““The good, the bad, and the ugly”: the role of chemokines in models of human disease,” Journal of Immunology, vol. 156, no. 10, pp. 3583–3586, 1996. View at Google Scholar · View at Scopus
  26. D. D. Taub, K. Conlon, A. R. Lloyd, J. J. Oppenheim, and D. J. Kelvin, “Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β,” Science, vol. 260, no. 5106, pp. 355–358, 1993. View at Google Scholar · View at Scopus
  27. R. R. Tamesis, E. M. Messmer, B. A. Rice, J. E. Dutt, and C. S. Foster, “The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice,” Eye, vol. 8, no. 3, pp. 298–306, 1994. View at Google Scholar · View at Scopus
  28. J. F. Metcalf, D. S. Hamilton, and R. W. Reichert, “Herpetic keratitis in athymic (nude) mice,” Infection and Immunity, vol. 26, no. 3, pp. 1164–1171, 1979. View at Google Scholar · View at Scopus
  29. R. G. Russell, M. P. Nasisse, H. S. Larsen, and B. T. Rouse, “Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis,” Investigative Ophthalmology and Visual Science, vol. 25, no. 8, pp. 938–944, 1984. View at Google Scholar · View at Scopus
  30. M. Z. Doymaz and B. T. Rouse, “Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes,” Investigative Ophthalmology and Visual Science, vol. 33, no. 7, pp. 2165–2173, 1992. View at Google Scholar · View at Scopus
  31. M. G. Niemialtowski and B. T. Rouse, “Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis,” Journal of Immunology, vol. 149, no. 9, pp. 3035–3039, 1992. View at Google Scholar · View at Scopus
  32. R. L. Hendricks, M. S. P. Tao, and J. C. Glorioso, “Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis,” Journal of Immunology, vol. 142, no. 1, pp. 263–269, 1989. View at Google Scholar · View at Scopus
  33. R. L. Hendricks and T. M. Tumpey, “Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology,” Investigative Ophthalmology and Visual Science, vol. 31, no. 10, pp. 1929–1939, 1990. View at Google Scholar · View at Scopus
  34. T. M. Tumpey, S. H. Chen, J. E. Oakes, and R. N. Lausch, “Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea,” Journal of Virology, vol. 70, no. 2, pp. 898–904, 1996. View at Google Scholar · View at Scopus
  35. J. Thomas, S. Gangappa, S. Kanangat, and B. T. Rouse, “On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis,” Journal of Immunology, vol. 158, no. 3, pp. 1383–1391, 1997. View at Google Scholar · View at Scopus
  36. J. K. Miller, K. A. Laycock, M. M. Nash, and J. S. Pepose, “Corneal Langerhans cell dynamics after herpes simplex virus reactivation,” Investigative Ophthalmology and Visual Science, vol. 34, no. 7, pp. 2282–2290, 1993. View at Google Scholar · View at Scopus
  37. D. N. Cook, M. A. Beck, T. M. Coffman et al., “Requirement of MIP-1α for an inflammatory response to viral infection,” Science, vol. 269, no. 5230, pp. 1583–1585, 1995. View at Google Scholar · View at Scopus
  38. T. M. Tumpey, H. Cheng, D. N. Cook, O. Smithies, J. E. Oakes, and R. N. Lausch, “Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis,” Agricultural and Forest Meteorology, vol. 97, no. 5, pp. 275–292, 1999. View at Google Scholar · View at Scopus
  39. X. T. Yan, T. M. Tumpey, S. L. Kunkel, J. E. Oakes, and R. N. Lausch, “Role of MBP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea,” Investigative Ophthalmology and Visual Science, vol. 39, no. 10, pp. 1854–1862, 1998. View at Google Scholar
  40. P. M. Stuart, J. E. Morris, M. Sidhu, and T. L. Keadle, “CCL3 protects mice from corneal pathology during recurrent HSV-1 infection,” Frontiers in Bioscience, vol. 13, no. 12, pp. 4407–4415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Colantonio, H. Recalde, F. Sinigaglia, and D. D'Ambrosio, “Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naive T cells into Th1 or Th2 cells,” European Journal of Immunology, vol. 32, no. 5, pp. 1264–1273, 2002. View at Google Scholar · View at Scopus
  42. R. R. Fenton, S. Molesworth-Kenyon, J. E. Oakes, and R. N. Lausch, “Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation,” Investigative Ophthalmology and Visual Science, vol. 43, no. 3, pp. 737–743, 2002. View at Google Scholar · View at Scopus
  43. T. M. Tumpey, H. Cheng, X. T. Yan, J. E. Oakes, and R. N. Lausch, “Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10,” Journal of Leukocyte Biology, vol. 63, no. 4, pp. 486–492, 1998. View at Google Scholar · View at Scopus
  44. B. Kim, P. P. Sarangi, Y. Lee, S. D. Kaistha, S. Lee, and B. T. Rouse, “Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation,” Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1405–1415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. S. K. Eo, S. Lee, S. Chun, and B. T. Rouse, “Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines,” Journal of Virology, vol. 75, no. 2, pp. 569–578, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. S. K. Lee, B. K. Choi, W. J. Kang et al., “MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis,” Molecules and Cells, vol. 26, no. 1, pp. 67–73, 2008. View at Google Scholar · View at Scopus
  47. R. Duan, L. Remeijer, J. M. van Dun, A. D. Osterhaus, and G. M. Verjans, “Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: Implications for the role of neutrophils in HSK,” Investigative Ophthalmology and Visual Science, vol. 48, no. 1, pp. 277–284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. Mikloska, V. A. Danis, S. Adams, A. R. Lloyd, D. L. Adrian, and A. L. Cunningham, “In vivo production of cytokines and β (C-C) chemokines in human recurrent herpes simplex lesions—do herpes simplex virus—infected keratinocytes contribute to their production?” Journal of Infectious Diseases, vol. 177, no. 4, pp. 827–838, 1998. View at Google Scholar · View at Scopus
  49. H. Li, J. Zhang, A. Kumar, M. Zheng, S. S. Atherton, and F. S. Yu, “Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells,” Immunology, vol. 117, no. 2, pp. 167–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. J. H. Dufour, M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster, “IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking,” Journal of Immunology, vol. 168, no. 7, pp. 3195–3204, 2002. View at Google Scholar · View at Scopus
  51. S. Lee, M. Zheng, S. Deshpande, S. K. Eo, T. A. Hamilton, and B. T. Rouse, “IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis,” Journal of Leukocyte Biology, vol. 71, no. 3, pp. 469–476, 2002. View at Google Scholar · View at Scopus
  52. D. J. Carr, J. Chodosh, J. Ash, and T. E. Lane, “Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection,” Journal of Virology, vol. 77, no. 18, pp. 10037–10046, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. H. F. Staats and R. N. Lausch, “Cytokine expression in vivo during murine herpetic stromal keratitis: effect of protective antibody therapy,” Journal of Immunology, vol. 151, no. 1, pp. 277–283, 1993. View at Google Scholar · View at Scopus
  54. P. S. Biswas, K. Banerjee, B. Kim, and B. T. Rouse, “Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis,” Journal of Immunology, vol. 172, no. 6, pp. 3736–3744, 2004. View at Google Scholar · View at Scopus
  55. A. Suryawanshi, T. Veiga-Parga, N. K. Rajasagi et al., “Role of il-17 and th17 cells in herpes simplex virus-induced corneal immunopathology,” Journal of Immunology, vol. 187, no. 4, pp. 1919–1930, 2011. View at Publisher · View at Google Scholar
  56. T. L. Keadle, K. A. Laycock, J. S. Pepose, and P. M. Stuart, “Proinflammatory cytokines IL-1 and TNF-α are required for recurrent herpetic keratitis in NIH mice,” Investigative Ophthalmology & Visual Science, vol. 41, pp. 96–102, 2000. View at Google Scholar
  57. J. S. Babu, S. Kanangat, and B. T. Rouse, “T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis,” Journal of Immunology, vol. 154, no. 9, pp. 4822–4829, 1995. View at Google Scholar · View at Scopus
  58. S. Kanangat, J. Thomas, S. Gangappa, J. S. Babu, and B. T. Rouse, “Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression: implications in immunopathogenesis and protection,” Journal of Immunology, vol. 156, no. 3, pp. 1110–1116, 1996. View at Google Scholar · View at Scopus
  59. C. Shimeld, D. L. Easty, and T. J. Hill, “Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and cytokines,” Journal of Virology, vol. 73, no. 3, pp. 1767–1773, 1999. View at Google Scholar · View at Scopus
  60. T. L. Keadle, N. Usui, K. A. Laycock, Y. Kumano, J. S. Pepose, and P. M. Stuart, “Cytokine expression in murine corneas during recurrent herpetic stromal keratitis,” Ocular Immunology and Inflammation, vol. 9, no. 3, pp. 193–205, 2001. View at Publisher · View at Google Scholar
  61. T. H. Stumpf, C. Shimeld, D. L. Easty, and T. J. Hill, “Cytokine production in a murine model of recurrent herpetic stromal keratitis,” Investigative Ophthalmology and Visual Science, vol. 42, no. 2, pp. 372–378, 2001. View at Google Scholar · View at Scopus
  62. T. R. Mosmann and R. L. Coffman, “TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties,” Annual Review of Immunology, vol. 7, pp. 145–173, 1989. View at Google Scholar · View at Scopus
  63. K. E. Graeber and N. J. Olsen, “Th17 cell cytokine secretion profile in host defense and autoimmunity,” Inflammation Research, vol. 61, no. 2, pp. 87–96, 2012. View at Publisher · View at Google Scholar
  64. R. L. Hendricks, T. M. Tumpey, and A. Finnegan, “IFN-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice,” Journal of Immunology, vol. 149, no. 9, pp. 3023–3028, 1992. View at Google Scholar · View at Scopus
  65. Q. Tang, W. Chen, and R. L. Hendricks, “Proinflammatory functions of IL-2 in herpes simplex virus corneal infection,” Journal of Immunology, vol. 158, no. 3, pp. 1275–1283, 1997. View at Google Scholar · View at Scopus
  66. K. Banerjee, P. S. Biswas, and B. T. Rouse, “Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis,” Journal of Interferon and Cytokine Research, vol. 27, no. 1, pp. 65–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. D. M. Bouley, S. Kanangat, W. Wire, and B. T. Rouse, “Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice,” Journal of Immunology, vol. 155, no. 8, pp. 3964–3971, 1995. View at Google Scholar · View at Scopus
  68. N. G. Jacobson, S. J. Szabo, R. M. Weber-Nordt et al., “Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4,” Journal of Experimental Medicine, vol. 181, no. 5, pp. 1755–1762, 1995. View at Google Scholar · View at Scopus
  69. T. L. Keadle, D. E. Alexander, D. A. Leib, and P. M. Stuart, “Interferon gamma is not required for recurrent herpetic stromal keratitis,” Virology, vol. 380, no. 1, pp. 46–51, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. T. M. Tumpey, V. M. Elner, S. H. Chen, J. E. Oakes, and R. N. Lausch, “Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1,” Journal of Immunology, vol. 153, no. 5, pp. 2258–2265, 1994. View at Google Scholar · View at Scopus
  71. M. Daheshia, N. Kuklin, S. Kanangat, E. Manickan, and B. T. Rouse, “Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10,” Journal of Immunology, vol. 159, no. 4, pp. 1945–1952, 1997. View at Google Scholar · View at Scopus
  72. T. L. Keadle and P. M. Stuart, “Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis,” Microbial Pathogenesis, vol. 38, no. 1, pp. 13–21, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. S. J. Molesworth-Kenyon, R. Yin, J. E. Oakes, and R. N. Lausch, “IL-17 receptor signaling influences virus-induced corneal inflammation,” Journal of Leukocyte Biology, vol. 83, no. 2, pp. 401–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. N. K. Rajasagi, P. B. Reddy, A. Suryawanshi, S. Mulik, P. Gjorstrup, and B. T. Rouse, “Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1,” Journal of Immunology, vol. 186, no. 3, pp. 1735–1746, 2011. View at Publisher · View at Google Scholar
  75. A. J. Lepisto, G. M. Frank, M. Xu, P. M. Stuart, and R. L. Hendricks, “CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice,” Investigative Ophthalmology and Visual Science, vol. 47, no. 8, pp. 3400–3409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. D. Bauer, S. Mrzyk, N. Van Rooijen, K. P. Steuhl, and A. Heiligenhaus, “Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages,” Experimental Eye Research, vol. 72, no. 3, pp. 261–269, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Xia, S. Zhang, J. Zhou, and Y. Li, “A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis,” Molecular Vision, vol. 16, pp. 2071–2083, 2010. View at Google Scholar · View at Scopus
  78. A. Heiligenhaus, H. Li, A. Schmitz, S. Wasmuth, and D. Bauer, “Improvement of herpetic stromal keratitis with fumaric acid derivate is associated with systemic induction of T helper 2 cytokines,” Clinical and Experimental Immunology, vol. 142, no. 1, pp. 180–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. T. L. Keadle, J. L. Morris, J. S. Pepose, and P. M. Stuart, “CD4+ and CD8+ cells are key participants in the development of recurrent herpetic stromal keratitis in mice,” Microbial Pathogenesis, vol. 32, no. 6, pp. 255–262, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. E. Chang, L. Galle, D. Maggs, D. M. Estes, and W. J. Mitchell, “Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice,” Journal of Virology, vol. 74, no. 24, pp. 11832–11840, 2000. View at Publisher · View at Google Scholar · View at Scopus
  81. T. L. Keadle, L. A. Morrison, J. L. Morris, J. S. Pepose, and P. M. Stuart, “Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection,” Journal of Virology, vol. 76, no. 8, pp. 3615–3625, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. E. R. Kearney, T. L. Walunas, R. W. Karr et al., “Antigen-dependent clonal expansion of a trace population of antigen- specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4,” Journal of Immunology, vol. 155, no. 3, pp. 1032–1036, 1995. View at Google Scholar · View at Scopus
  83. S. Gangappa, E. Manickan, and B. T. Rouse, “Control of herpetic stromal keratitis using CTLA4Ig fusion protein,” Clinical Immunology and Immunopathology, vol. 86, no. 1, pp. 88–94, 1998. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Osorio, S. Cai, and H. Ghiasi, “Treatment of mice with anti-CD86 mAb reduces CD8+ T cell-mediated CTL activity and enhances ocular viral replication in HSV-1-infected mice,” Ocular Immunology and Inflammation, vol. 13, no. 2-3, pp. 159–167, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Xu, A. J. Lepisto, and R. L. Hendricks, “CD154 signaling regulates the Th1 response to herpes simplex virus-1 and inflammation in infected corneas,” Journal of Immunology, vol. 173, no. 2, pp. 1232–1239, 2004. View at Google Scholar · View at Scopus
  86. A. J. Lepisto, M. Xu, H. Yagita, A. D. Weinberg, and R. L. Hendricks, “Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis,” Journal of Leukocyte Biology, vol. 81, no. 3, pp. 766–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. S. K. Seo, H. Y. Park, J. H. Choi et al., “Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis,” Journal of Immunology, vol. 171, no. 2, pp. 576–583, 2003. View at Google Scholar · View at Scopus
  88. Y. H. Kim, S. K. Seo, B. K. Choi et al., “4-1BB costimulation enhances HSV-1-specific CD8+ T cell responses by the induction of CD11c+CD8+ T cells,” Cellular Immunology, vol. 238, no. 2, pp. 76–86, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Liu, Q. Tang, and R. L. Hendricks, “Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection,” Journal of Virology, vol. 70, no. 1, pp. 264–271, 1996. View at Google Scholar · View at Scopus
  90. T. Liu, K. M. Khanna, B. N. Carriere, and R. L. Hendricks, “Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons,” Journal of Virology, vol. 75, no. 22, pp. 11178–11184, 2001. View at Publisher · View at Google Scholar · View at Scopus
  91. K. Khanna, R. Bonneau, P. Kinchington, and R. L. Hendricks, “Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia,” Immunity, vol. 18, no. 5, pp. 593–603, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. V. Decman, P. R. Kinchington, S. A. Harvey, and R. L. Hendricks, “Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression,” Journal of Virology, vol. 79, no. 16, pp. 10339–10347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. K. Hüfner, T. Derfuss, S. Herberger et al., “Latency of α-herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia,” Journal of Neuropathology and Experimental Neurology, vol. 65, no. 10, pp. 1022–1030, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. G. M. Verjans, R. Q. Hintzen, J. M. van Dun et al., “Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 9, pp. 3496–3501, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. J. E. Knickelbein, K. M. Khanna, M. B. Yee, C. J. Baty, P. R. Kinchington, and R. L. Hendricks, “Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency,” Science, vol. 322, no. 5899, pp. 268–271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. G. M. Frank, A. J. Lepisto, M. L. Freeman, B. S. Sheridan, T. L. Cherpes, and R. L. Hendricks, “Early CD4+ T cell help prevents partial CD8+ T cell exhaustion and promotes maintenance of herpes simplex virus 1 latency,” Journal of Immunology, vol. 184, no. 1, pp. 277–286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. N. A. DeLuca, A. M. McCarthy, and P. A. Schaffer, “Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4,” Journal of Virology, vol. 56, no. 2, pp. 558–570, 1985. View at Google Scholar · View at Scopus
  98. A. J. St. Leger, B. Peters, J. Sidney, A. Sette, and R. L. Hendricks, “Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice,” Journal of Immunology, vol. 186, no. 7, pp. 3927–3933, 2011. View at Publisher · View at Google Scholar
  99. H. Ghiasi, S. Bahri, A. B. Nesburn, and S. L. Wechsler, “Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins,” Investigative Ophthalmology and Visual Science, vol. 36, no. 7, pp. 1352–1360, 1995. View at Google Scholar · View at Scopus
  100. Heiligenhaus, P. A. Wells, and C. S. Foster, “Immunisation against HSV-1 keratitis with a synthetic gD peptide,” Eye, vol. 9, no. 1, pp. 89–95, 1995. View at Google Scholar · View at Scopus
  101. Y. Inoue, Y. Ohashi, Y. Shimomura et al., “Herpes simplex virus glycoprotein D. Protective immunity against murine herpetic keratitis,” Investigative Ophthalmology and Visual Science, vol. 31, no. 3, pp. 411–418, 1990. View at Google Scholar
  102. A. B. Nesburn, R. L. Burke, H. Ghiasi, S. Slanina, and S. L. Wechsler, “Intramuscular vaccination of rabbits with expressed HSV-2 glycoproteins B+D (gD2+gD2) protects against death following ocular HSV-1 challenge but not from eye disease,” Investigative Ophthalmology & Visual Science, vol. 35, pp. 1679–1686, 1994. View at Google Scholar
  103. J. Walker and D. A. Leib, “Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host shutoff (vhs) function,” Vaccine, vol. 16, no. 1, pp. 1–5, 1998. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Walker, K. A. Laycock, J. S. Pepose, and D. A. Leib, “Postexposure vaccination with a virion host shutoff defective mutant reduces UV-B radiation-induced ocular herpes simplex virus shedding in mice,” Vaccine, vol. 16, no. 1, pp. 6–8, 1998. View at Publisher · View at Google Scholar · View at Scopus
  105. A. B. Nesburn, R. L. Burke, H. Ghiasi, S. Slanina, S. Bahri, and S. L. Wechsler, “Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits,” Journal of Virology, vol. 68, no. 8, pp. 5084–5092, 1994. View at Google Scholar · View at Scopus
  106. A. B. Nesburn, R. L. Burke, H. Gbiasi, S. M. Slanina, and S. L. Wechsler, “A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease,” Investigative Ophthalmology and Visual Science, vol. 39, no. 7, pp. 1163–1170, 1998. View at Google Scholar
  107. L. R. Stanberry, S. L. Spruance, A. L. Cunningham et al., “Glycoprotein-D-adjuvant vaccine to prevent genital herpes,” The New England Journal of Medicine, vol. 347, no. 21, pp. 1652–1661, 2002. View at Publisher · View at Google Scholar
  108. L. I. Strelow and D. A. Leib, “Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis,” Journal of Virology, vol. 69, no. 11, pp. 6779–6786, 1995. View at Google Scholar · View at Scopus
  109. T. L. Keadle, J. Walker, K. A. Laycock et al., “Therapeutic vaccination with vhs- herpes simplex virus (HSV) reduces severity of recurrent herpetic stromal keratitis in mice,” Journal of General Virology, vol. 83, no. 10, pp. 2361–2365, 2002. View at Google Scholar
  110. J. E. Schrimpf, E. M. Tu, H. Wang, Y. M. Wong, and L. A. Morrison, “B7 costimulation molecules encoded by replication-defective, vhs-deficient HSV-1 improve vaccine-induced protection against corneal disease,” Plos ONE, vol. 6, no. 8, 2011. View at Publisher · View at Google Scholar
  111. C. M. Richards, R. Case, T. R. Hirst, T. J. Hill, and N. A. Williams, “Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice,” Journal of Virology, vol. 77, no. 12, pp. 6692–6699, 2003. View at Publisher · View at Google Scholar · View at Scopus
  112. W. J. Karpus, J. G. Pope, J. D. Peterson, M. C. Dal Canto, and S. D. Miller, “Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction,” Journal of Immunology, vol. 155, no. 2, pp. 947–957, 1995. View at Google Scholar · View at Scopus
  113. W. J. Karpus, J. D. Peterson, and S. D. Miller, “Anergy in vivo: down-regulation of antigen-specific CD4+ Th1 but not Th2 cytokine responses,” International Immunology, vol. 6, no. 5, pp. 721–730, 1994. View at Google Scholar · View at Scopus
  114. P. P. Sarangi, S. Sehrawat, S. Suvas, and B. T. Rouse, “IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology,” Journal of Immunology, vol. 180, no. 9, pp. 6297–6306, 2008. View at Google Scholar · View at Scopus
  115. S. SehraWat and B. T. Rouse, “Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators,” Journal of Immunology, vol. 180, no. 11, pp. 7636–7647, 2008. View at Google Scholar · View at Scopus